Literature DB >> 12748267

Lysogeny and bacteriophage host range within the Burkholderia cepacia complex.

Ross Langley1, Dervla T Kenna1, Peter Vandamme1, Rebecca Ure1, John R W Govan1.   

Abstract

The Burkholderia cepacia complex comprises a group of nine closely related species that have emerged as life-threatening pulmonary pathogens in immunocompromised patients, particularly individuals with cystic fibrosis or chronic granulomatous disease. Attempts to explain the genomic plasticity, adaptability and virulence of the complex have paid little attention to bacteriophages, particularly the potential contribution of lysogenic conversion and transduction. In this study, lysogeny was observed in 10 of 20 representative strains of the B. cepacia complex. Three temperate phages and five lytic phages isolated from soils, river sediments or the plant rhizosphere were chosen for further study. Six phages exhibited T-even morphology and two were lambda-like. The host range of individual phages, when tested against 66 strains of the B. cepacia complex and a representative panel of other pseudomonads, was not species-specific within the B. cepacia complex and, in some phages, included Burkholderia gladioli and Pseudomonas aeruginosa. These new data indicate a potential role for phages of the B. cepacia complex in the evolution of these soil bacteria as pathogens of plants, humans and animals, and as novel therapeutic agents.

Entities:  

Mesh:

Year:  2003        PMID: 12748267     DOI: 10.1099/jmm.0.05099-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  20 in total

Review 1.  Role of phages in the pathogenesis of Burkholderia, or 'Where are the toxin genes in Burkholderia phages?'.

Authors:  Elizabeth J Summer; Jason J Gill; Chris Upton; Carlos F Gonzalez; Ry Young
Journal:  Curr Opin Microbiol       Date:  2007-08-23       Impact factor: 7.934

2.  Statistical structure of host-phage interactions.

Authors:  Cesar O Flores; Justin R Meyer; Sergi Valverde; Lauren Farr; Joshua S Weitz
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

3.  Genomes and characterization of phages Bcep22 and BcepIL02, founders of a novel phage type in Burkholderia cenocepacia.

Authors:  Jason J Gill; Elizabeth J Summer; William K Russell; Stephanie M Cologna; Thomas M Carlile; Alicia C Fuller; Kate Kitsopoulos; Leslie M Mebane; Brandi N Parkinson; David Sullivan; Lisa A Carmody; Carlos F Gonzalez; John J LiPuma; Ry Young
Journal:  J Bacteriol       Date:  2011-07-29       Impact factor: 3.490

4.  Experimental phage therapy in treating Klebsiella pneumoniae-mediated liver abscesses and bacteremia in mice.

Authors:  Chih-Hsin Hung; Chih-Feng Kuo; Chiou-Huey Wang; Ching-Ming Wu; Nina Tsao
Journal:  Antimicrob Agents Chemother       Date:  2011-01-18       Impact factor: 5.191

5.  Cultivation-based assessment of lysogeny among soil bacteria.

Authors:  Kurt E Williamson; Jennifer B Schnitker; Mark Radosevich; David W Smith; K Eric Wommack
Journal:  Microb Ecol       Date:  2008-03-06       Impact factor: 4.552

6.  The proportional lack of archaeal pathogens: Do viruses/phages hold the key?

Authors:  Erin E Gill; Fiona S L Brinkman
Journal:  Bioessays       Date:  2011-02-15       Impact factor: 4.345

7.  Comparative analysis of two phenotypically-similar but genomically-distinct Burkholderia cenocepacia-specific bacteriophages.

Authors:  Karlene H Lynch; Paul Stothard; Jonathan J Dennis
Journal:  BMC Genomics       Date:  2012-06-07       Impact factor: 3.969

8.  Classification of Myoviridae bacteriophages using protein sequence similarity.

Authors:  Rob Lavigne; Paul Darius; Elizabeth J Summer; Donald Seto; Padmanabhan Mahadevan; Anders S Nilsson; Hans W Ackermann; Andrew M Kropinski
Journal:  BMC Microbiol       Date:  2009-10-26       Impact factor: 3.605

Review 9.  The promise of bacteriophage therapy for Burkholderia cepacia complex respiratory infections.

Authors:  Diana D Semler; Karlene H Lynch; Jonathan J Dennis
Journal:  Front Cell Infect Microbiol       Date:  2012-01-20       Impact factor: 5.293

Review 10.  A genetic approach to the development of new therapeutic phages to fight pseudomonas aeruginosa in wound infections.

Authors:  Victor Krylov; Olga Shaburova; Sergey Krylov; Elena Pleteneva
Journal:  Viruses       Date:  2012-12-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.